Day: April 26, 2022

Progressive Announces Investor Relations Call

Progressive Announces Investor Relations Call

MAYFIELD VILLAGE, OHIO, April 26, 2022 (GLOBE NEWSWIRE) — As previously announced, The Progressive Corporation (NYSE: PGR) will host an Investor Relations conference call on Tuesday, May 3, 2022, beginning at 9:30 a.m. eastern time. Consistent with past Investor Relations calls, this quarterly call, which will consist of both a conference call and an audio only webcast, is scheduled to last 60 minutes and will include a question-and-answer session with Tricia Griffith, our CEO, and John Sauerland, our CFO. Call-in participants will be able to ask questions via the phone. The webcast will be in a listen-only format and, therefore, participants will not be able to submit questions. On May 2, 2022, Progressive expects to file its Quarterly Report on Form 10-Q with the Securities and Exchange Commission and post its Shareholders’ Report,...

Continue reading

Selectis Health Postpones Fourth Quarter and Full Year 2021 Conference Call, Originally Scheduled for April 26, 2022 at 4:30 p.m. Eastern Time

Selectis Health Postpones Fourth Quarter and Full Year 2021 Conference Call, Originally Scheduled for April 26, 2022 at 4:30 p.m. Eastern Time

Greenwood Village, CO, April 26, 2022 (GLOBE NEWSWIRE) — Selectis Health, Inc. (OTC: GBCS) (“Selectis” or the “Company”) announced that it will be postponing its scheduled conference call on Tuesday, April 26, 2022 at 4:30 p.m. ET to discuss its financial results for the fourth quarter and full year ended December 31, 2021. The postponement is due to additional time needed to finalize the audit of its 2021 financial statements. The Company remains committed to reporting its fourth quarter and full year 2021 financial results as soon as practicable. Selectis expects to provide an update on timing for the rescheduled conference call within the next few business days and issue revised call details once confirmed. About Selectis Health Selectis Health owns and/or operates healthcare facilities in Arkansas, Georgia,...

Continue reading

Mason Graphite Provides Disclosure on Going-Public Transaction of Black Swan Graphene

Mason Graphite Provides Disclosure on Going-Public Transaction of Black Swan Graphene

MONTREAL, April 26, 2022 (GLOBE NEWSWIRE) — Further to its press release dated December 21, 2021 and the press releases of Dragonfly Capital Corp. (“Dragonfly”) dated December 16, 2021, January 27, 2022, and March 14, 2022, and as requested by the TSX Venture Exchange (the “TSX-V”), Mason Graphite Inc. (“Mason Graphite” or the “Company“) (TSX-V: LLG; OTCQX: MGPHF) provides the following disclosure on the qualifying transaction between Dragonfly and Black Swan Graphene Inc. (“Black Swan Graphene”). On December 13, 2021, Dragonfly and Black Swan Graphene entered into a binding letter of intent (the “LOI”), pursuant to which Dragonfly and Black Swan Graphene (each, a “Party” and together, the “Parties”) have agreed to complete a business combination whereby Dragonfly will acquire all of the issued and outstanding...

Continue reading

Chairman Comments from the Annual Shareholder Meeting held on April 26, 2022

Chairman Comments from the Annual Shareholder Meeting held on April 26, 2022

Fort Lauderdale, FL, April 26, 2022 (GLOBE NEWSWIRE) — OptimumBank Holdings, Inc. (OPHC-NASDAQ). Similar to my comments at last year’s Annual Shareholder meeting, I want to focus today on our past year’s results and discuss what we expect 2022 will look like. We cannot really understand last year without understanding how we arrived at 2021. Our story really is all about growth. For years the Company was limited on what we were allowed to do because of circumstances that preceded any of our current management or board members. I have been fortunate to have an excellent team with me on the board of directors and I take the responsibility seriously as their chairman. Last year we had one board member retire and we were fortunate to gain my business partner Michael Blisko as a board member. From the start, Michael added a new level...

Continue reading

BC Craft Announces Unanimous Creditor Approval of Proposal

BC Craft Announces Unanimous Creditor Approval of Proposal

VANCOUVER, British Columbia, April 26, 2022 (GLOBE NEWSWIRE) — BC Craft Supply Co Ltd. (the “Company”) is pleased to announce the unanimous approval of the Company’s proposal to its creditors (the “Proposal”) at the meeting (the “Meeting”) of certain of its creditors (the “Affected Creditors”). The proposal was approved by 100% in number of Affected Creditors who represent 100% in value of the eligible voting claims of Affected Creditors who were present and voted in person or by proxy on the Proposal at the Meeting and who were entitled to vote at the Meeting in accordance with the Proposal and Bankruptcy and Insolvency Act (Canada) (“BIA”). This approval represents a “Required Majority” under the Proposal. “We are pleased with the overwhelming vote of support...

Continue reading

Lake City Bank Named to KBW Bank Honor Roll of High Performing Banks for the 11th Consecutive Year

Lake City Bank Named to KBW Bank Honor Roll of High Performing Banks for the 11th Consecutive Year

WARSAW, Ind., April 26, 2022 (GLOBE NEWSWIRE) — Lake City Bank, the single bank subsidiary of Lakeland Financial Corporation (Nasdaq Global Select/LKFN), announced today that the bank’s long term performance earned it inclusion in the 2022 KBW Bank Honor Roll published by Keefe Bruyette & Woods, Inc. (KBW), the 11th consecutive year that the bank has earned a place in the listing. Lake City Bank is one of 17 banking institutions, just 5% of all banks screened, that met KBW’s criteria for inclusion in the 2022 Bank Honor Roll; 14 banks are returning members to the list. KBW Bank Honor Roll members have better-than industry performance ratios and growth rates when compared to the publicly traded bank universe with total assets greater than $500 million, which includes 350 companies listed on the NYSE and Nasdaq exchanges. “We...

Continue reading

Molecular Partners Provides Update on Ensovibep Following Novartis Quarterly Earnings Call

Molecular Partners Provides Update on Ensovibep Following Novartis Quarterly Earnings Call

ZURICH-SCHLIEREN, Switzerland & CONCORD, Mass., April 26, 2022 (GLOBE NEWSWIRE) — Ad hoc announcement pursuant to Art. 53 LR: Molecular Partners AG (SIX: MOLN; NASDAQ: MOLN), a clinical-stage biotech company developing a new class of custom-built protein drugs known as DARPin therapeutics, is providing an update following comments provided by Novartis during its quarterly earnings call today. In the call, Novartis’ CEO, Vas Narasimhan stated that Emergency Use Application (EUA) for ensovibep, which is filed and in review with the U.S. Food and Drug Administration (FDA), may require additional clinical data to be authorized. Vas Narasimhan also noted the current omicron wave of SARS-Cov-2, and the lower incidents of hospitalization associated with it, has made clinical investigations challenging to execute in this evolving...

Continue reading

Nokia Corporation: Repurchase of own shares on 26.04.2022

Nokia Corporation: Repurchase of own shares on 26.04.2022

Nokia CorporationStock Exchange Release26 April 2022 at 21:00 EEST Nokia Corporation: Repurchase of own shares on 26.04.2022 Espoo, Finland – On 26 April 2022 Nokia Corporation (LEI: 549300A0JPRWG1KI7U06) has acquired its own shares (ISIN FI0009000681) as follows: Trading venue (MIC Code) Number of shares Weighted average price / share, EUR* XHEL 268,190 4.91 CEUX 741 4.91 AQEU 5,054 4.92 TQEX 1,015 4.88 Total 275,000 4.91 * Rounded to two decimals On 3 February 2022, Nokia announced that its Board of Directors is initiating a share buyback program under the authorization granted by Nokia’s Annual General Meeting on 8 April 2021 to return up to EUR 600 million of cash to shareholders in tranches over a period of two years. The first phase of the share buyback program in compliance with the Market Abuse Regulation (EU) 596/2014...

Continue reading

Sanofi: Information concerning the total number of voting rights and shares – March 2022

Sanofi: Information concerning the total number of voting rights and shares – March 2022

Information concerning the total number of voting rights and shares, provided pursuant to article L. 233-8 II of the Code de commerce (the French Commercial Code) and article 223-16 of the Règlement général de l’Autorité des Marchés Financiers (Regulation of the French stock market authority) Sanofia French société anonyme with a registered share capital of 2,527,121,390 €Registered office : 54, rue La Boétie – 75008 Paris – FranceRegistered at the Paris Commercial and Companies Registry under number 395 030 844 Date   Total number of issued shares   Number of real voting rights(excluding treasury shares) Theoretical number of voting rights (including treasury shares)* March 31, 2022 1,263,652,104 1,405,063,509 1,420,057,193 * Pursuant to article 223-11 of the Règlement général de l’Autorité des Marchés...

Continue reading

Veritex Community Bank Expands Houston Banking Team

Veritex Community Bank Expands Houston Banking Team

New additions to focus on Middle-Market Banking, Commercial Real Estate, Private Banking and Professional Services HOUSTON, April 26, 2022 (GLOBE NEWSWIRE) — (www.veritexbank.com) Veritex Community Bank, a Texas headquartered bank specializing in providing depository and credit services to small to mid-sized businesses, has appointed William Ray Jr as EVP and managing director for middle-market banking, Brent Reed as EVP director of commercial real estate, and Will Richardson as EVP for private banking. All three individuals are joining from Bank of Houston, where they held senior-level positions. Ray joins the company with more than 18 years of banking experience and a robust background in building and managing banking teams focused on core C&I banking in the Houston area. Notably, Ray spent 14 years at Amegy Bank as a commercial...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Cookie Notice

We use cookies to improve your experience on our website

Information we collect about your use of Goldea Capital website

Goldea Capital website collects personal data about visitors to its website.

When someone visits our websites, we use a third party service, Google Analytics, to collect standard internet log information (such as IP address and type of browser they’re using) and details of visitor behavior patterns. We do this to allow us to keep track of the number of visitors to the various parts of the sites and understand how our website is used. We do not make any attempt to find out the identities or nature of those visiting our websites. We won’t share your information with any other organizations for marketing, market research or commercial purposes and we don’t pass on your details to other websites.

Use of cookies
Cookies are small text files that are placed on your computer or other device by websites that you visit. They are widely used to make websites work, or work more efficiently, as well as to provide information to the owners of the site.